Y-27632 Dihydrochloride: Selective ROCK Inhibitor for Cytoskeletal and Stem Cell Studies

Executive Summary: Y-27632 dihydrochloride (A3008) is a small-molecule inhibitor with nanomolar potency and high selectivity for Rho-associated protein kinases (ROCK1/2), making it integral to studies of cytoskeletal organization, cell cycle regulation, and stem cell viability (Zhang et al., 2025; ApexBio A3008). It exhibits an IC50 of ~140 nM for ROCK1 and a Ki of 300 nM for ROCK2, with >200-fold selectivity over kinases such as PKC and PKA. Y-27632 is highly soluble in DMSO (≥111.2 mg/mL) and supports robust experimental protocols in cell culture and animal models. The compound has been shown to enhance stem cell survival, suppress tumor invasion, and facilitate organoid culture. Integration into workflows requires temperature-controlled solubilization and careful storage below -20°C (ApexBio A3008).

Biological Rationale

Rho-associated protein kinases (ROCK1 and ROCK2) are serine/threonine kinases that mediate actin cytoskeleton rearrangement, stress fiber formation, and cell contractility. The Rho/ROCK pathway regulates key cellular processes such as proliferation, motility, and cytokinesis (Zhang et al., 2025). Dysregulation of this pathway is implicated in cancer progression, stem cell aging, and tissue fibrosis. Selective ROCK inhibition is a validated strategy to dissect these mechanisms in both basic and translational research. Y-27632 dihydrochloride enables researchers to model the effects of Rho/ROCK pathway inhibition with high precision, particularly in contexts where cytoskeletal dynamics and cell survival are critical, such as in the maintenance of stem cell niches and the suppression of aberrant cell migration.

Mechanism of Action of Y-27632 Dihydrochloride

Y-27632 dihydrochloride is a cell-permeable inhibitor that binds to the ATP-binding pocket of ROCK1 and ROCK2 catalytic domains, blocking kinase activity. Key quantitative parameters: IC50 for ROCK1 is ~140 nM; Ki for ROCK2 is 300 nM. Selectivity is >200-fold over other kinases, including protein kinase C (PKC), cAMP-dependent protein kinase (PKA), myosin light chain kinase (MLCK), and p21-activated kinase (PAK) (ApexBio A3008). Inhibition of ROCK activity disrupts phosphorylation of downstream targets such as myosin light chain (MLC), resulting in reduced actin-myosin contractility, loss of stress fibers, and altered cell morphology. This disruption impacts cell cycle progression, particularly the G1/S transition, and inhibits cytokinesis, which can reduce proliferation rates in various cell types, including prostatic smooth muscle cells and tumor lines.

Evidence & Benchmarks

• Y-27632 inhibits ROCK1 with an IC50 of approximately 140 nM in cell-free kinase assays (ApexBio A3008).
• Displays over 200-fold selectivity for ROCK1/2 versus PKC, PKA, MLCK, and PAK, minimizing off-target effects (ApexBio A3008).
• Reduces proliferation of prostatic smooth muscle cells in a concentration-dependent manner in vitro (ApexBio A3008).
• Suppresses tumor invasion and metastasis in mouse models, supporting its utility in cancer research (Zhang et al., 2025).
• Enhances survival and viability of human intestinal stem cells (ISCs) during organoid culture by modulating cytoskeletal tension (Zhang et al., 2025).
• Facilitates the formation of crypt-like structures in ISC organoid models, providing a tool for regenerative medicine studies (Zhang et al., 2025).

For a broader mechanistic analysis, see Y-27632 Dihydrochloride: Precision ROCK Inhibition for Cell Cycle and Cytoskeletal Studies, which is extended here by explicit benchmarking data and organoid context.

Applications, Limits & Misconceptions

Y-27632 dihydrochloride is widely applied in:

• Enhancing stem cell viability during isolation and passaging, notably for human pluripotent and intestinal stem cells (Zhang et al., 2025).
• Dissecting the role of Rho/ROCK signaling in tumor invasion and metastasis in preclinical models.
• Facilitating three-dimensional organoid culture by promoting survival and crypt formation.
• Modulating cytoskeletal organization and stress fiber formation in cell biology assays.

For advanced niche modeling, Y-27632 Dihydrochloride: ROCK Inhibition in Paneth Cell and ISC Niche Research explores the Paneth cell–ISC axis, which this article updates with new findings on in vivo human tissue benchmarks.

Common Pitfalls or Misconceptions

• Y-27632 is not a general kinase inhibitor; its activity is highly selective for ROCK1/2 and does not significantly inhibit PKC, PKA, MLCK, or PAK at standard working concentrations.
• Long-term storage of Y-27632 solutions, especially at room temperature or above −20°C, can lead to degradation and reduced efficacy.
• It does not directly reverse stem cell aging but facilitates stem cell survival by modulating cytoskeletal tension (Zhang et al., 2025).
• In vivo use requires careful dosing and pharmacokinetic consideration, as off-target effects may emerge outside the nanomolar range.
• Y-27632 cannot replace growth factors or niche signals needed for full ISC function in organoid systems.

For a guide to microenvironmental strategies and troubleshooting, see Y-27632 Dihydrochloride: Advanced Strategies for Microenvironment Engineering, which this review clarifies with new selectivity and storage data.

Workflow Integration & Parameters

Solubility: Y-27632 is soluble at ≥111.2 mg/mL in DMSO, ≥17.57 mg/mL in ethanol, and ≥52.9 mg/mL in water. Solubility can be improved by warming to 37°C or using an ultrasonic bath. Prepare concentrated stock solutions, aliquot, and store at <−20°C to avoid repeated freeze–thaw cycles (ApexBio A3008).

Dosing and Application: For cell culture, working concentrations typically range from 1–20 μM. In organoid and stem cell cultures, 10 μM is a common starting point for enhancing viability. For in vivo studies, refer to published protocols to ensure pharmacodynamic compatibility.

Experimental Controls: Always include vehicle and/or non-inhibitor controls. Monitor for changes in cell morphology, proliferation, and marker expression.

For protocol optimization in stem cell and cancer workflows, consult Y-27632 Dihydrochloride: Targeted ROCK Inhibition for Stem Cell and Cancer Biology, which this article updates by integrating new data on storage and cytoskeletal benchmarks.

Conclusion & Outlook

Y-27632 dihydrochloride is a rigorously validated, selective ROCK1/2 inhibitor. Its utility in dissecting cytoskeletal physiology, supporting stem cell viability, and suppressing tumor invasion is well established. Key parameters—nanomolar potency, high selectivity, and robust solubility—make it a preferred tool in cell and cancer biology. Ongoing research, particularly in ISC aging and organoid engineering, is expanding its applications. For specifications and ordering, visit the Y-27632 dihydrochloride product page.